Towards Healthcare
Genome Editing Market | Shares | Companies Report by 2033

Genome Editing Market Size (USD 38.43 Billion) Report by 2033

The report covers Genome Editing Market Segments categorized in terms of applications addressing genetic engineering, encompassing cell line engineering, animal genetic engineering, plant genetic engineering and others. Clinical applications explores diagnostics and therapy development. Technologies highlights CRISPR/Cas9, TALENs/MegaTALs, ZFN, Meganuclease and other methods. Delivery methods are ex-vivo and in-vivo approaches. End-users includes biotechnology and pharmaceutical companies, academic and government research institutes, as well as contract research organizations. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Genome Editing Market Assessment

  • Overview
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Region (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • MEA

North America Genome Editing Market Assessment

  • Overview
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Europe Genome Editing Market Assessment

  • Overview
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Asia Pacific Genome Editing Market Assessment

  • Overview
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Latin America Genome Editing Market Assessment

  • Overview
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

MEA Genome Editing Market Assessment

  • Overview
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Company Profiles

  • Thermo Fisher Scientific, Inc
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Lonza
  • Bluebird Bio, Inc.
  • OriGene Technologies, Inc.
  • New England Biolabs
  • Genscript Biotech Corp
  • Transposagen Biopharmaceuticals, Inc.
  • Danaher Corporation
  • Horizon Discovery Ltd. (Revvity, Inc.)
  • Takara Bio Inc.
  • AstraZeneca
  • Cellectis S.A.
  • Caribou Biosciences, Inc
  • Intellia Therapeutics, Inc.
  • CRISPR Therapeutics
  • Precision BioSciences
  • Editas Medicine
  • Sangamo Therapeutics
  • Recombinetics
  • Cibus Inc.
  • Merck KGaA

Conclusion & Recommendations

  • Insight Code: 5161
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

Genetically engineered animal models of CVD have been made possible thanks to the development of CRISPR-based germline genome editing techniques. CRISPR-based gene editing techniques are quicker, simpler to use, and more widely applicable than traditional gene targeting methods that utilize embryonic stem cells.

In an effort to treat sickness or strengthen the body resistance to illness, gene therapy attempts to correct a damaged gene or replace it with a healthy one. Numerous illnesses, including cancer, AIDS, diabetes, heart disease, cystic fibrosis, and hemophilia, may benefit from it as a treatment.

World Health Organization, National Heart, Lung, and Blood Institute, FDA, The White House, USAD, Press Information Bureau.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 465

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 465